PFBT
IMVT icon

Parkside Financial Bank & Trust’s Immunovant IMVT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56K Hold
63
– – ﹤0.01% 2204
2025
Q4 		$1.6K Hold
63
– – ﹤0.01% 2178
2025
Q3 		$1.02K Hold
63
– – ﹤0.01% 2281
2025
Q2 		$1.01K Buy
+63
New +$953 ﹤0.01% 2269

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Parkside Financial Bank & Trust's IMVT Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Immunovant (IMVT) position steady in Q1 2026 at 63 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2204.

Parkside Financial Bank & Trust first reported a position in IMVT in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.6K in Q4 2025. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Parkside Financial Bank & Trust held 63 shares of Immunovant worth $1.56K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Immunovant share count unchanged in Q1 2026.
  • Immunovant made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2204 holding.
  • Parkside Financial Bank & Trust first reported a position in Immunovant in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Immunovant position peaked at $1.6K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.